Ads
related to: abbvie stock- Read AbbVie Stories
Read Stories About Our Science,
People, and More Today.
- AbbVie News Center
See Our Achievements, Growth Story,
and More Today.
- Investor Resources
Find Financial Reports, Stock Info
And More Resources For Investors.
- Supporting Our Workforce
Embracing Equality & Diversity
Makes Us More Innovative.
- Read AbbVie Stories
Search results
AbbVie Stock Falls As Company Warns of Continued Humira Sales Slump
Investopedia· 4 days agoShares of AbbVie (ABBV) slumped Friday as the pharmaceutical firm warned of deeper declines in sales...
5 stocks to watch on Friday: XOM, CVX, ABBV and more
Seeking Alpha· 4 days agoExxon Mobil (XOM), Chevron (CVX), AbbVie (ABBV), Skechers (SKX) and Atlassian (TEAM) are the stocks to watch on Friday.
Jim Cramer's quick thoughts on 5 stocks: Chevron, Snap, Intel, AbbVie and Colgate
CNBC· 4 days agoChevron : The oil giant beat on quarterly earnings but missed on revenue. "Maybe this is a chance to...
AbbVie Raises Earnings Guidance Even as Humira Sales Continue to Drop
Barrons.com· 4 days agoAbbVie raised its full-year earnings outlook despite continuing sales declines for autoimmune drug...
Gear Up for AbbVie (ABBV) Q1 Earnings: Wall Street Estimates for Key Metrics
Zacks via Yahoo Finance· 7 days agoGet a deeper insight into the potential performance of AbbVie (ABBV) for the quarter ended March...
AbbVie hikes 2024 earnings guidance as Q1 beat estimates, shares up
Investing.com· 4 days agoAbbVie hikes 2024 earnings guidance as Q1 beat estimates, shares up
AbbVie raises earnings forecast on strong immunology drug growth
Crain s Chicago Business· 4 days agoHumira sales declined 35% in the quarter to $2.2 billion, dragging down sales in AbbVie’s entire immunology portfolio by 4% to $5.3 billion. In response, AbbVie< ...
AbbVie (ABBV) to Release Quarterly Earnings on Friday
ETF DAILY NEWS· 5 days agoAbbVie (NYSE:ABBV – Get Free Report) is scheduled to be issuing its quarterly earnings data before the market opens on Friday, April 26th. Analysts expect the company to announce ...
Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie
Zacks via Yahoo Finance· 5 days agoIn oncology, AbbVie also has an exciting and diverse pipeline of promising new therapies in both...
Here’s why ImmunityBio (IBRX) stock price surged and what next | Invezz
Invezz· 7 days agoImmunityBio (NASDAQ: IBRX) stock price resumed its strong rally this week after the company achieved...